Latest Technological Innovations for Defense and Security Industry Disrupting the Future of Military Operations

PR Newswire


MarketNewsUpdates


News Commentary


NEW YORK
, Aug. 27, 2025 /PRNewswire/ — The landscape of emerging technologies in the defense sector, from sustainable materials and advanced sensing capabilities to innovative power solutions, highlights the urgent need for rapid acquisition processes, such as Other Transaction Authorities, to ensure that the government can swiftly integrate these innovations and maintain a strategic advantage in an increasingly complex global environment. A report from NSTXL.org, an industry insider in the emerging technologies in the defense markets reported that: “In an era where technological advancements are rapidly reshaping military operations, acquisition processes within the government are a key element to success. The defense industry is experiencing a surge of emerging technologies that promise to enhance capabilities and improve operational efficiency. From artificial intelligence and machine learning to innovative materials and novel detection methods, these advancements are crucial for maintaining a competitive edge. Recent technical presentations at the National Defense Industrial Association (NDIA) Emerging Technologies conference in Washington, D.C. highlighted a variety of groundbreaking developments, showcasing the imperative for the government to adapt quickly and utilize the Other Transaction Authority (OTA) in order to harness these innovations for national security.” Active Companies leading the way in military & defense operations include VisionWave Holdings Inc. (NASDAQ: VWAV), L3Harris Technologies, Inc. (NYSE: LHX), RTX Corporation (NYSE: RTX), Rocket Lab Corporation (NASDAQ: RKLB), Leidos Holdings, Inc. (NYSE: LDOS).

NSTXL.org continued: “Emerging technologies in the defense industry are shaping the future of military capabilities, with several innovative developments recently highlighted. Here are a few upcoming technical capabilities to pay attention to: AI and ML are advancing scientific discovery and analysis within the defense sector. AI is perfect for military applications because it can solve computational complexity. It can easily run an algorithm during times of tremendous pressure and stress. Also, it can decide at a much faster speed; Niron Magnetics has introduced Iron Nitride as the first new permanent magnet in four decades. This innovative material is completely free of rare earth elements, making it both sustainable and recyclable, with significant implications for industries relying on magnets, projected to grow from a $45 billion market today to $180 billion by 2035; Unmanned aerial systems (UAS) have become an integral part of modern military operations. They are also known as drones. Skydweller Aero invented a solar-powered aircraft, capable of providing persistent intelligence, surveillance, and reconnaissance (ISR) without the need for batteries, combining efficiency with significant operational range; Sandbox AQ is discussing the potential of quantum sensing technologies to enhance mission perception and operational advantage. Quantum communication plays a key role in the security of space-based communication systems, making it a necessary technology for maintaining space safety. Quantum technology is one of many critical tech areas supported by the Space Enterprise Consortium (SpEC) OTA.”

VisionWave (NASDAQ: VWAV) Enters into Strategic Joint Venture Agreement with AIPHEX LTD, GBT Tokenize Corp., and GBT Technologies, Inc. – VisionWave Holdings Inc. ($VWAV), (“VisionWave” or the “Company”) issued an 8-K that on August 25, 2025 the Company has entered into a Strategic Joint Venture Agreement (the “Agreement”) with AIPHEX LTD (“AIPHEX”), GBT Tokenize Corp. (“TOKENIZE”), and GBT Technologies, Inc. (“GBT”). Pursuant to the Agreement, the parties agreed to form a joint venture limited liability company in the State of Nevada (the “JV LLC”) for the purpose of collaborating on certain designated defense and technology projects (the “Designated Projects and Background IP”). The Designated Projects and Background IP are set forth in a separate confidential letter agreement between the Company and AIPHEX due to their sensitive and confidential nature.

These ownership percentages are based on an estimated internal value of $5,000,000,000 for equity allocation purposes, with the parties waiving the need for formal valuation solely for this allocation and shall not be constructed as a valuation of AIPHEX or its assets for any other purpose. TOKENIZE will contribute to the JV 897,102 shares of the Company’s common stock and its intellectual property portfolio (as detailed in Exhibit A to the Agreement). GBT will contribute to the JV 2,020,500 shares of the Company’s common stock. AIPHEX will contribute the Designated Projects and Background IP. The Company and AIPHEX will each enter into non-exclusive license agreements granting the JV LLC rights to use certain of their respective intellectual property portfolios and products solely for the Designated Projects and Background IP (the “JV License Agreements”). The JV LLC will serve as the exclusive vehicle for marketing, manufacturing, delivering, and managing the Designated Projects, including research, development, commercialization, and related activities. The parties will adopt an operating agreement for the JV LLC within 30 days of the effective date. The Agreement includes provisions for board appointments, including the reciprocal right for the Company and AIPHEX to appoint one individual to each other’s board of directors (subject to approvals), with initial advisory board appointments for Dr. Moshik Cohen (to the Company’s advisory board) and Noam Kenig (to AIPHEX’s advisory board). Read More About Dr. Moshik Cohen by scrolling below.

Upon approval, Dr. Moshik Cohen will be appointed to the Company’s board of directors and granted options to purchase 2,000,000 shares of the Company’s common stock under the Company’s equity incentive plan. Intellectual property developed by the JV LLC will be owned by the JV LLC, with restrictions on use and transfer. Both AIPHEX and the Company contribute the Designated Projects (DP) to the JV and each will enter into the JV License Agreements. The Agreement includes non-circumvention provisions, confidentiality obligations, and termination rights, including a provision that the Agreement becomes void and considerations returned if no revenue is generated from the Designated Projects within 12 months of establishing the JV LLC. The term of the Agreement is seven years, subject to renewal. The Agreement also provides for a referral fee to a non-affiliated third-party, consisting of 700,000 shares of the Company’s common stock (to be assigned from shares contributed to the JV LLC and which will not be issued by the Company in any manner) and 2% of future JV LLC revenue based on actual collections.

The transactions contemplated by the Agreement are subject to customary closing conditions, including obtaining necessary regulatory approvals (such as CFIUS clearance, export control licenses, and other governmental consents). The parties intend to consummate the contributions and operationalize the JV LLC upon execution of the operating agreement and satisfaction of such conditions. Continued… Read this full 8-K for VWAV by visiting: https://www.nasdaq.com/market-activity/stocks/vwav/sec-filings


About Dr. Moshik Cohen

: Dr. Cohen holds a PhD in Physical Electronics and has led groundbreaking research in plasmonics, nanophotonics, and quantum systems. His contributions have been featured in Nature, Science, and other top-tier scientific journals, advancing global understanding of how plasmonic technologies can unlock near-light-speed computing.

Dr. Cohen is an accomplished entrepreneur and technology leader based in Israel. He is currently the Founder and CEO of a stealth-mode startup, where he leverages his extensive background in applied research and deep technology. His professional journey includes significant roles in various high-tech companies, notably as the Founder and CEO of Wisense Technologies, where he has made advancements in RADAR technology since November 2017. Cohen’s current work in stealth mode suggests that he is developing innovative technologies that are not yet publicly disclosed. His past experiences and expertise in both the defense and high-tech sectors position him well for future endeavors in cutting-edge technology development.

Other recent developments in the military/defense industries include:

L3Harris Technologies, Inc. (NYSE: LHX) has recently completed a $100 million expansion at its satellite integration and test facility in Palm Bay to support the Department of Defense’s (DOD) urgent need for on-orbit technology for the Golden Dome for America. L3Harris’ new investment in Florida adds to the existing capability of the Space Coast and will enable key components for this strategic capability to be delivered during President Trump’s second term.

Elected officials, customers and business leaders participated in a ribbon-cutting ceremony today for the expanded 94,000-square-foot facility, designed to produce next-generation satellites that will identify, track and defend against hypersonic and advanced missile threats.

In partnership with the U.S. Navy, Raytheon, an RTX Corporation (NYSE: RTX) business, has recently and successfully completed its first live test of the AN/SPY-6(V)4 radar in a maritime environment. The milestone was achieved during recent testing at the Advanced Radar Detection Laboratory located at the Pacific Missile Range Facility in Hawaii.

During multiple tests over open water, the radar successfully tracked air and surface targets under various conditions. These tests demonstrated the radar’s advanced tracking capabilities across different mission scenarios and validated years of modeling and simulation work. Additionally, the tests yielded the first live data set for the (V)4 configuration, which will help refine the system for future testing and eventual shipboard deployment.

Rocket Lab Corporation (NASDAQ: RKLB) recently announced it is boosting its U.S. investments to expand semiconductor manufacturing capacity and provide supply chain security for space-grade solar cells and electro-optical sensors for national security space missions. The Trump Administration will support these investments with a $23.9 million award through the Department of Commerce, part of the CHIPS and Science Act that ensures U.S. leadership in space-grade semiconductor technology.

In a strategic response to the increasing demand for a robust domestic supply chain of space-grade solar cells and electro-optical sensors for spacecrafts and satellites, Rocket Lab’s capital investments over the next five years are expected to strengthen the Company’s market position as a leading satellite manufacturer, components supplier, and end-to-end mission provider for commercial and national security space missions. Rocket Lab is one of only two companies in the United States that specialize in the production of high efficiency, radiation hardened, space-grade compound semiconductors.

In support of advancing secure information sharing across agencies and allied nations, including efforts tied to AUKUS Pillar 2, Leidos Holdings, Inc. (NYSE: LDOS) recently achieved Trusted Secure Enclave (TSE) Vetted Partner status from Amazon Web Services (AWS). This premier designation is awarded to organizations that meet the highest standards for secure enclave design and deployment.

At the core of this designation is the Leidos Secure Environment (LSE), a cloud-based, automated infrastructure and governance platform built on AWS TSE. LSE enables secure collaboration across multi-organization and international environments, allowing global teams to jointly conduct design, research, and development for sensitive workloads and data.

DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU’S market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated forty nine hundred dollars for news coverage of the current press releases issued by VisionWave Holdings, Inc. by the Company. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Contact Information:

Media Contact email: [email protected]
– +1(561)486-1799

Logo: https://mma.prnewswire.com/media/2737336/5478667/MarketNewsUpdates.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/latest-technological-innovations-for-defense-and-security-industry-disrupting-the-future-of-military-operations-302539643.html

SOURCE MarketNewsUpdates

Highland Opportunities and Income Fund Announces Investor Update Call

PR Newswire


DALLAS
, Aug. 27, 2025 /PRNewswire/ — The Highland Opportunities and Income Fund (NYSE:HFRO) (“HFRO” or the “Fund”) announced today that the Fund is scheduled to host a conference call on Tuesday, September 23, 2025, at 10:00 a.m. CT, to discuss portfolio updates and recent performance.

To register to attend the call click here or visit Highland Opportunities and Income Fund Website and follow the link to register.

Attendees may submit questions ahead of the call. Questions can be submitted through the registration link. A replay will be available on HFRO’s website after the call.

About the Highland Opportunities and Income Fund

The Highland Opportunities and Income Fund (NYSE: HFRO) is a closed-end fund managed by NexPoint Asset Management, L.P. For more information visit Highland Opportunities and Income Fund Website.

About NexPoint Asset Management, L.P.

NexPoint Asset Management, L.P. is an SEC-registered investment adviser. It is the adviser to a suite of registered funds, including open-end mutual funds, and closed-end funds. For more information visit nexpointassetmgmt.com.


Disclosures

Before investing in the Fund, you should carefully consider the Fund’s investment objectives, risks, charges, and expenses. For a copy of a prospectus or summary prospectus, which contains this and other information, please visit our website at www.nexpointassetmgmt.com or call 1-800-357-9167. Please read the fund prospectus carefully before investing.

Shares of closed-end investment companies frequently trade at a discount to NAV. The price of the Fund’s shares is determined by a number of factors, several of which are beyond the control of the Fund. Therefore, the Fund cannot predict whether its shares will trade at, below or above net asset value. Past performance does not guarantee future results.

CONTACTS

Investor Relations

Kristen Griffith

[email protected]

Media Relations

[email protected]

 

Cision View original content:https://www.prnewswire.com/news-releases/highland-opportunities-and-income-fund-announces-investor-update-call-302539673.html

SOURCE Highland Opportunities and Income Fund

Avidity Biosciences to Participate in Upcoming Investor Conferences

PR Newswire


SAN DIEGO
, Aug. 27, 2025 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that Avidity management will participate in a fireside chat during the following investor conferences:

  • Cantor Global Healthcare Conference 2025 – New York, NY

    Wednesday, September 3, 2025, at 7:20 a.m. PT | 10:20 a.m. ET
  • 2025 Wells Fargo Healthcare Conference – Everett, MA

    Thursday, September 4, 2025, at 9:45 a.m. PT | 12:45 p.m. ET
  • Morgan Stanley 23rd Annual Global Healthcare Conference – New York, NY

    Monday, September 8, 2025, at 10:50 a.m. PT | 1:50 p.m. ET

Live webcasts of each event, up-to-date event details and archived replays will be available on the “Events and Presentations” page in the “Investors” section of Avidity’s website at https://aviditybiosciences.investorroom.com/events-and-presentations.

About Avidity

Avidity Biosciences, Inc.’s mission is to profoundly improve people’s lives by delivering a new class of RNA therapeutics – Antibody Oligonucleotide Conjugates (AOCs™). Avidity is revolutionizing the field of RNA with its proprietary AOCs, which are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA therapies. Utilizing its proprietary AOC platform, Avidity demonstrated the first-ever successful targeted delivery of RNA into muscle and is leading the field with clinical development programs for three rare muscle diseases: myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). Avidity is also advancing two wholly-owned precision cardiology development candidates addressing rare genetic cardiomyopathies. In addition, Avidity is broadening the reach of AOCs with its advancing and expanding pipeline including programs in cardiology and immunology through key partnerships. Avidity is headquartered in San Diego, CA. For more information about our AOC platform, clinical development pipeline and people, please visit www.aviditybiosciences.com and engage with us on LinkedIn and X.

Investor Contact:
Kat Lange
(619) 837-5014
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/avidity-biosciences-to-participate-in-upcoming-investor-conferences-302538395.html

SOURCE Avidity Biosciences, Inc.

OpenText and Ponemon Institute Survey of CIOs Finds Lack of Information Readiness Threatens AI Success

PR Newswire

New research of almost 1,900 CIOs, CISOs, and other IT leaders shows they are under pressure to ensure sensitive information is secure and compliant without hindering growth


WATERLOO, ON
, Aug. 27, 2025 /PRNewswire/ — OpenText™ (NASDAQ: OTEX) (TSX: OTEX) today released a new global report, “The Challenges to Ensuring Information Is Secure, Compliant and Ready for AI,” revealing that while enterprise IT leaders recognize the transformative potential of AI, a gap in information readiness is causing their organizations to struggle in securing, governing, and aligning AI initiatives across business.

Developed in partnership with the Ponemon Institute — a leading, independent research firm focused on information security and privacy management — the study revealed almost three-quarters (73%) of CIOs, CISOs, and other IT leaders believe reducing information complexity is key to AI readiness.

“This research confirms what we’re hearing from CIOs every day. AI is mission-critical, but most organizations aren’t ready to support it,” said Shannon Bell, Chief Digital Officer, OpenText. “Without trusted, well-governed information, AI can’t deliver on its promise. At OpenText, we’re helping IT and security leaders close that gap by simplifying information complexity, strengthening governance, and ensuring the right information is secure and actionable across the enterprise.”

Information Readiness Is the Missing Link in AI Success

While AI is a high priority, the research underscores a key gap, that most organizations lack the information readiness to deploy AI securely or effectively. The report also found that while IT and security leaders remain confident in the ROI of AI, it is difficult to adopt, secure, and govern.

As this gap widens, information management is becoming the connective tissue between enabling innovation and maintaining trust. OpenText helps close that gap, by equipping leaders with the tools to simplify complexity, confidently govern data, and operationalize AI responsibly.

  • Information complexity impedes readiness: 73% say reducing complexity is essential (23%), very important (23%) and important (27%) for a strong security posture, with unstructured data (44%) among the top contributors to complexity.

  • Data governance is the first line of defense: To address data security risks in AI, nearly half (46%) of respondents say they are developing a data security program and practice.

  • Confidence is lagging: Just 43% are very or highly confident in their ability to measure ROI on securing and managing information assets.

The AI Paradox: High Confidence in ROI, Low Readiness in Execution

Leaders are optimistic about the value AI can deliver, but readiness is low. Many organizations still lack the security, governance, and alignment needed to deploy AI responsibly.

  • 57% of respondents rate AI adoption as a top priority, and 54% are confident they can demonstrate ROI from AI initiatives. However, 53% say it is “very difficult” or “extremely difficult” to reduce AI security and legal risks.
  • Fewer than half (47%) say IT and security goals are aligned with those driving AI strategy, even though 50% of respondents say their organizations have hired or are considering hiring a chief AI officer or a chief digital officer to lead AI strategy.
  • GenAI is gaining traction, with 32% having adopted it, and another 26% planning to in the next six months. Top GenAI use cases include security operations (39%), employee productivity (36%), and software development (34%).
  • Yet only 19% of organizations have adopted agentic AI and 16% will adopt it in the next six months. Just 31% of those rate agentic AI as highly important to their business strategy.

Improving Information and AI Readiness

The research also revealed best practices for achieving AI readiness based on responses from the organizations that have invested in AI. These include:

  • Protect sensitive data exposure: Organizations should know where sensitive data resides, who can access it, and how it is used. Strong access controls, clear data classification policies and anomaly detection tools can help reduce exposure.

  • Implement responsible AI practices: A comprehensive approach includes data cleansing and governance, validating AI inputs and outputs, employee training, and regular model bias checks to ensure AI is used safely and ethically.

  • Strengthen encryption: Encryption should be applied to data in storage, transit and during AI processing. This ensures that sensitive information remains protected throughout the AI lifecycle.

The full report also reveals additional pressures from insider risk, proving ROI of AI and IT investments, and managing security complexity.

Survey Methodology

The Ponemon Institute independently surveyed 1,896 senior IT and security leaders across North America, the United Kingdom, France, Germany, Australia, and India. The study captured input from organizations of varying sizes and industries, including financial services, healthcare, technology, and manufacturing. The research was conducted in May 2025. Respondents included CIOs, CISOs, IT and cybersecurity executives, and decision-makers responsible for AI and security strategy.

Additional Resources

  • Read the full report for more on broader AI and IT priorities, security trends, and investments: Click here

About OpenText 

OpenText™ is a leading Cloud and AI company that provides organizations around the world with a comprehensive suite of Business AI, Business Clouds, and Business Technology. We help organizations grow, innovate, become more efficient and effective, and do so in a trusted and secure way – through Information Management. For more information about OpenText (NASDAQ/TSX: OTEX), please visit us at www.opentext.com.  

Connect with us:

OpenText Thought Leadership

Twitter | LinkedIn

Certain statements in this press release may contain words considered forward-looking statements or information under applicable securities laws. These statements are based on OpenText’s current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which the company operates. These statements are subject to important assumptions, risks and uncertainties that are difficult to predict, and the actual outcome may be materially different. OpenText’s assumptions, although considered reasonable by the company at the date of this press release, may prove to be inaccurate and consequently its actual results could differ materially from the expectations set out herein. For additional information with respect to risks and other factors which could occur, see OpenText’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other securities filings with the SEC and other securities regulators. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Unless otherwise required by applicable securities laws, OpenText disclaims any intention or obligations to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Further, readers should note that we may announce information using our website, press releases, securities law filings, public conference calls, webcasts and the social media channels identified on the Investors section of our website (https://investors.opentext.com). Such social media channels may include the Company’s or our CEO’s blog, Twitter account or LinkedIn account. The information posted through such channels may be material. Accordingly, readers should monitor such channels in addition to our other forms of communication.

Copyright © 2025 OpenText. All Rights Reserved. Trademarks owned by OpenText. One or more patents may cover this product(s). For more information, please visit https://www.opentext.com/patents.

OTEX-G

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/opentext-and-ponemon-institute-survey-of-cios-finds-lack-of-information-readiness-threatens-ai-success-302539676.html

SOURCE Open Text Corporation

Scotiabank’s President and Chief Executive Officer Scott Thomson to Speak at the 26th Annual Scotiabank Global Banking and Markets Financials Summit

Canada NewsWire


TORONTO
, Aug. 27, 2025 /CNW/ – Scott Thomson, Scotiabank’s President and Chief Executive Officer, will speak at the 26th Annual Scotiabank Global Banking and Markets Financials Summit in Toronto on September 3, 2025. The conference features executives from Canada’s leading financial services companies, who will discuss their corporate strategies and current topics and trends in the financial markets.

Mr. Thomson is scheduled to participate in a fireside chat from approximately 9:00 a.m. to 9:30 a.m. ET. Interested parties may listen to the session live on Scotiabank’s Investor Relations page. An archived version of the webcast will be available after the conference.

About Scotiabank
Scotiabank’s vision is to be our clients’ most trusted financial partner and deliver sustainable, profitable growth. Guided by our purpose: “for every future,” we help our clients, their families and their communities achieve success through a broad range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. With assets of approximately $1.4 trillion (as at July 31, 2025), Scotiabank is one of the largest banks in North America by assets, and trades on the Toronto Stock Exchange (TSX: BNS) and New York Stock Exchange (NYSE: BNS). For more information, please visit www.scotiabank.com and follow us on X @Scotiabank.

SOURCE Scotiabank

Truist to present at the Barclays Global Financial Services Conference

PR Newswire


CHARLOTTE, N.C.
, Aug. 27, 2025 /PRNewswire/ — Truist Financial Corporation (NYSE: TFC) today announced that Chief Financial Officer Mike Maguire will present at the Barclays Global Financial Services Conference at 11:15 a.m. ET on Tuesday, Sept. 9, 2025, in New York City.

A live audio webcast will be available the day of the event at ir.truist.com under Events & Presentations. A replay of the webcast will be available on the website for 30 days.


About Truist

Truist Financial Corporation is a purpose-driven financial services company committed to inspiring and building better lives and communities. Headquartered in Charlotte, North Carolina, Truist has leading market share in many of the high-growth markets in the U.S. and offers a wide range of products and services through wholesale and consumer businesses, including consumer and small business banking, commercial and corporate banking, investment banking and capital markets, wealth management, payments, and specialized lending businesses. Truist is a top-10 commercial bank with total assets of $544 billion as of June 30, 2025. Truist Bank, Member FDIC. Equal Housing Lender. Learn more at Truist.com.

Cision View original content:https://www.prnewswire.com/news-releases/truist-to-present-at-the-barclays-global-financial-services-conference-302539442.html

SOURCE Truist Financial Corporation

Penumbra, Inc. Names Shruthi Narayan as Company President

PR Newswire


ALAMEDA, Calif.
, Aug. 27, 2025 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), the world’s leading thrombectomy company, today announced the promotion of Shruthi Narayan to President of the company, effective September 1, 2025. She will continue to report to Adam Elsesser, who served in the role of President prior to this promotion and will continue in his roles as chairman of the board and chief executive officer of Penumbra.  

“Shruthi is a dynamic, seasoned leader whose passion for innovation and proven ability to inspire global teams make her the obvious choice for this critical role,” said Mr. Elsesser. “Her vision and focus on excellence will undoubtedly help sustain Penumbra’s exceptional growth and market leadership, expanding access to our life-saving technology to patients around the world.”

A 20-year veteran in the medical device industry, Ms. Narayan was most recently president of Penumbra’s interventional business where she led the day-to-day operations and oversaw the growth initiatives of both the company’s neuro and vascular franchises. She joined Penumbra in 2013 as a product manager starting off on the stroke franchise, then transitioning to help build the peripheral vascular division, commercializing Penumbra’s vascular portfolio of embolization and thrombectomy products globally. Ms. Narayan began her medical device career at Medtronic in 2006, working in engineering, regulatory affairs and then in the cardiovascular sales organization.

“Penumbra has been at the forefront of blood clot care for more than 20 years, advancing the most innovative technologies to address conditions from head-to-toe like stroke and pulmonary embolism,” said Ms. Narayan. “I am honored to carry on and expand our legacy of innovation and look forward to continuing this paradigm shift in patient care.”

Ms. Narayan received a B.S. in Electrical Engineering from Anna University, India and a M.S. in Biomedical Engineering from University of Southern California, with a focus on Medical Device Commercialization.

About Penumbra
Penumbra, Inc., the world’s leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Forward-Looking Statements
Except for historical information, certain statements in this press release are forward-looking in nature and are subject to risks, uncertainties and assumptions about us. Our business and operations are subject to a variety of risks and uncertainties and, consequently, actual results may differ materially from those projected by any forward-looking statements. Factors that could cause actual results to differ from those projected include, but are not limited to: failure to sustain or grow profitability or generate positive cash flows; failure to effectively introduce and market new products; delays in product introductions; significant competition; inability to further penetrate our current customer base, expand our user base and increase the frequency of use of our products by our customers; inability to achieve or maintain satisfactory pricing and margins; manufacturing difficulties; permanent write-downs or write-offs of our inventory or other assets; product defects or failures; unfavorable outcomes in clinical trials; inability to maintain our culture as we grow; fluctuations in foreign currency exchange rates; potential adverse regulatory actions; and the potential impact of any acquisitions, mergers, dispositions, joint ventures or investments we may make. These risks and uncertainties, as well as others, are discussed in greater detail in our filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 18, 2025. There may be additional risks of which we are not presently aware or that we currently believe are immaterial which could have an adverse impact on our business. Any forward-looking statements are based on our current expectations, estimates and assumptions regarding future events and are applicable only as of the dates of such statements. We make no commitment to revise or update any forward-looking statements in order to reflect events or circumstances that may change.

Investor Relations
Penumbra, Inc.
[email protected]

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-names-shruthi-narayan-as-company-president-302539462.html

SOURCE Penumbra, Inc.

Qualys Achieves FedRAMP High Authorization for Comprehensive Risk Management Platform

PR Newswire

Leading cyber risk management company meets the highest federal standard to serve its growing public sector customer base


FOSTER CITY, Calif.
, Aug. 27, 2025 /PRNewswire/ — Qualys, Inc. (NASDAQ: QLYS), a leading provider of disruptive cloud-based IT, security, and compliance solutions, today announced the Qualys Government Platform has achieved FedRAMP(R) High Authorization, sponsored by the U.S. Drug Enforcement Agency (DEA). This authorization makes Qualys one of the few cybersecurity platforms offering a full-spectrum security solution at the FedRAMP High level and positions it among an elite group of vendors trusted to support the federal government’s most sensitive systems.

Many federal agencies struggle with limited staff and fragmented security tools, making it hard to assess and manage cyber risk. Qualys addresses this with a unified cyber risk management platform that delivers broad visibility and control across the entire risk surface. Now FedRAMP High Authorized, the Qualys Government Platform offers vulnerability management, compliance, endpoint detection and response (EDR), asset inventory, policy enforcement, web application security, and soon cloud-native application protection – all in a single, scalable solution designed to meet the highest federal security standards.

FedRAMP High is the most rigorous authorization level within the Federal Risk and Authorization Management Program, aligning with NIST 800-53 High Impact controls. It is reserved for cloud services that handle the government’s most sensitive, unclassified data. Platforms at this level are designed to support mission and business critical workloads.

“Achieving FedRAMP High Authorization underscores our significant investment in best-in-class security and reaffirms our commitment as a trusted partner in advancing the U.S. Federal Government’s mission to strengthen cybersecurity,” said Sumedh Thakar, president and CEO of Qualys. “As threats grow, organizations need unified visibility, scalable automation, and confidence in their security stack. This milestone demonstrates that the Qualys Government Platform enables customers to efficiently reduce risk and safeguard their most critical assets across public and private sectors.”

Availability

Qualys Government Cloud is available on the FedRAMP marketplace at qualys.com/fedramp-marketplace. To request a demo, visit qualys.com/gov, read the blog at qualys.com/fedramp-high-blog, or register for the webinar, Operationalize Cyber Risk Reduction with FedRAMP.

Additional Resources 

About Qualys  

Qualys, Inc. (NASDAQ: QLYS) is a leading provider of disruptive cloud-based security, compliance and IT solutions with more than 10,000 subscription customers worldwide, including a majority of the Forbes Global 100 and Fortune 100. Qualys helps organizations streamline and automate their security and compliance solutions onto a single platform for greater agility, better business outcomes, and substantial cost savings.

The Qualys Enterprise TruRisk Platform leverages a single agent to continuously deliver critical security intelligence while enabling enterprises to automate the full spectrum of vulnerability detection, compliance, and protection for IT systems, workloads and web applications across on premises, endpoints, servers, public and private clouds, containers, and mobile devices. Founded in 1999 as one of the first SaaS security companies, Qualys has strategic partnerships and seamlessly integrates its vulnerability management capabilities into security offerings from cloud service providers, including Oracle Cloud Infrastructure, Amazon Web Services, the Google Cloud Platform and Microsoft Azure, along with a number of leading managed service providers and global consulting organizations. For more information, please visit http://www.qualys.com.

Qualys, Qualys VMDR®, Qualys TruRisk and the Qualys logo are proprietary trademarks of Qualys, Inc. All other products or names may be trademarks of their respective companies. 

Media Contact:   
Tami Casey 
Qualys
[email protected] 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/qualys-achieves-fedramp-high-authorization-for-comprehensive-risk-management-platform-302539323.html

SOURCE Qualys, Inc.

Foremost Clean Energy Announces Positive Radon Survey Results on its Wolverine Uranium Property, Athabasca Basin, Saskatchewan

Highlights Include:

  • Elevated linear radon trends including a one-kilometer-long anomaly trending northeast
  • Second anomaly detected in the northeast portion of the grid, both of which remain open along strike
  • Survey results reinforce the property’s exploration potential

VANCOUVER, British Columbia, Aug. 27, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to announce the results of its recently completed radon survey, at the Wolverine Uranium Property (“Wolverine”), located in the world-renowned Athabasca Basin region of northern Saskatchewan, approximately 15 kilometers southeast of the Cigar Lake Mine site (see Figure 1). The radon survey, previously announced on June 25, 2025, was conducted by RadonEx Ltd. consisting of both radon flux monitoring over land and a small radon-in-water component to test adjacent wetlands. A total of 893 data points were collected over the survey grid. The survey grid was designed to cover two potential faults which may explain the notable unconformity offset1 observed on the property (see Figure 2).

Jason Barnard, President and CEO states “These survey results provide strong evidence that the interpreted structures at Wolverine are associated with elevated radon anomalies which may suggest the presence of subsurface uranium. This strengthens our confidence that the property has the right geological setting to host high-grade unconformity-style uranium mineralization. With these results in hand, our technical team will now integrate the radon data with historical geophysical and drill information to refine high-priority drill targets for future testing. We look forward to advancing Wolverine, which looks like another highly promising project to the ten-project portfolio we have optioned from Denison Mines. We are eager to advance our understanding of this site and systematically unlock any significant mineral potential.”

Radon Survey Results and Structural Interpretation

Radon surveying is geochemical approach which leverages the relationship between radon gas emissions and the presence of subsurface uranium. As uranium decays, it produces radon gas as one of its daughter products. Because radon is a gas, it can migrate toward the surface, particularly along faults and fractures, where it can be detected and measured.

Results from the radon flux monitoring identified elevated radon trends within the property, including a one-kilometer-long anomaly trending northeast and a second anomaly in the northeast portion of the grid, both of which remain open along strike (see Figure 3).

To better visualize survey results, Foremost has ranked all radon flux values relative to the highest value collected during the program. The maximum value is ranked “10”, with all other results scaled accordingly. This ranked dataset highlights a pronounced NNE-trending radon anomaly that closely coincides with an interpreted structural feature on the property (see Figure 3). While the radon trend closely parallels the structure, it is slightly offset, which is expected given that the structure is interpreted from magnetics reflecting basement rocks, whereas radon values are measured at surface. This correlation suggests that the structure may be fertile and represents a compelling target for future drill programs.

About the Wolverine Property

Wolverine is part of Foremost’s unique collaboration with Denison Mines Corp. (TSX: DML, NYSE American: DNN) and consists of three mineral claims totaling 12,444 acres (5,036 hectares). Historic work has been conducted on Wolverine by various companies including geophysical surveys and drilling programs. Previous exploration identified uranium mineralization, including drill hole WL10-01 that intersected 2,087 ppm U over 0.1 meters2. Numerous airborne and ground-based geophysical surveys suggest a complex, structural architecture on the property. Drilling from 2011-2014 indicates up to 50m of unconformity displacement. The controlling fault is non-conductive and its precise location is uncertain.

Next Steps

Foremost intends to integrate the results with historical geochemical and geophysical data to refine high-priority drill targets, which could form the basis for future drill testing of the property.

Figure 1. Wolverine Property in Regional Context



Figure 2. Wolverine Property Compilation Map



Figure 3. Wolverine Property Radon Survey Results Map

Qualified Person

The technical content of this news release has been reviewed and approved by Cameron MacKay, P. Geo., Vice President of Exploration for Foremost Clean Energy Ltd., and a Qualified Person under National Instrument 43-101, who has prepared and reviewed the content of this press release.

A qualified person has not performed sufficient work or data verification to validate the historical results in accordance with National Instrument 43-101. Although the historical results may not be reliable, the Company nevertheless believes that they provide an indication of the property’s potential and are relevant for any future exploration program.

About
Foremost

Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (WKN: A3DCC8) is a rapidly growing North American uranium and lithium exploration company. The Company holds an option holds an option from Denison Mines Corp. (“Denison”) to earn up to a 70% interest in 10 prospective uranium properties (with the exception of the Hatchet Lake, where Foremost is able to earn up to 51%), spanning over 330,000 acres in the prolific, uranium-rich Athabasca Basin region of northern Saskatchewan. As the demand for carbon-free energy continues to accelerate, domestically mined uranium and lithium are poised for dynamic growth, playing an important role in the future of clean energy. Foremost’s uranium projects are at different stages of exploration, from grassroots to those with significant historical exploration and drill-ready targets. The Company’s mission is to make significant discoveries alongside and in collaboration with Denison through systematic and disciplined exploration programs.

Foremost also has a portfolio of lithium projects at varying stages of development, which are located across 55,000+ acres in Manitoba and Quebec. For further information, please visit the Company’s website at www.foremostcleanenergy.com.

Contact and Information

Company

Jason Barnard, President and CEO
+1 (604) 330-8067 
[email protected]

Follow us or contact us on social media:

X: @fmstcleanenergy
LinkedIn: https://www.linkedin.com/company/foremostcleanenergy  
Facebook: https://www.facebook.com/ForemostCleanEnergy

Forward-Looking Statements

Except for the statements of historical fact contained herein, the information presented in this news release and oral statements made from time to time by representatives of the Company are or may constitute “forward-looking statements” as such term is used in applicable United States and Canadian laws and including, without limitation, within the meaning of the Private Securities Litigation Reform Act of 1995, for which the Company claims the protection of the safe harbor for forward-looking statements. These statements relate to statements regarding expectations with respect to energy and uranium demand and the Company’s exploration plans and objectives. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect,” “is expected,” “anticipates” or “does not anticipate,” “plans,” “estimates” or “intends,” or stating that certain actions, events or results “may,” “could,” “would,” “might” or “will” be taken, occur or be achieved) are not statements of historical fact and should be viewed as forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, continuity of agreements with third parties and satisfaction of the conditions to the option agreement with Denison, risks and uncertainties associated with the environment, delays in obtaining governmental approvals, permits or financing. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities. Please refer to the Company’s most recent filings under its profile on Sedar+ at www.sedarplus.ca and on Edgar at www.sec.gov for further information respecting the risks affecting the Company and its business.

The CSE has neither approved nor disapproves the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof
.


1 Unconformity Offset Interpreted from drillhole logs. See Saskatchewan Mineral Assessment Files 74H053, 74H15-0068 and 74H10-0071
2 See Saskatchewan Mineral Assessment File 74H15-0068.


Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/58fd187f-43ae-4ebc-9fd8-de787e63d305

https://www.globenewswire.com/NewsRoom/AttachmentNg/0b10d290-4067-4bcf-a3ee-08716082df00

https://www.globenewswire.com/NewsRoom/AttachmentNg/744e3e1f-fd5c-4e9c-a348-07088c6ad545



InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference

MIAMI, Aug. 27, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 27th Annual Global Investment Conference on Wednesday, September 10th at 10:00am Eastern Time (ET).

A live audio webcast and replay of the presentation may be accessed on the “Investor Calendar” section of the company’s website at: https://inspiremd.com/investors/investor-calendar/

About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

Investor Contacts:

Webb Campbell
Gilmartin Group LLC
[email protected]
[email protected]